#ESMOBreast Berlin is a wrap! Amazing and delightfully intimate meeting. Enjoyed connecting with experts, colleagues, and friends from across the global oncology community, including the phenomenally talented Menarini Stemline global team. Danke schön to all. Next stop, ASCO!
Clinical trial outcomes and real-world evidence: ORSERDU has both. See the data at the ESR1 mBC RWE website linked in the description.
Please see full Prescribing Information at link in bio.
ORSERDU has efficacy in the EMERALD trial
and has real-world evidence in clinical
practice. Visit the ESR1 mBC RWE website
linked in the description to see the latest data.
Please see full Prescribing Information at link in bio.
Visit https://t.co/2wZ4493Y73 to learn why it’s the 2L treatment of choice for ESR1 mutations, even with difficult-to-treat mBC.
Please see full Prescribing Information at link in bio.
We look forward to connecting with the global oncology community and engaging in discussions that will shape the future of cancer care. If you're attending, we'd love to connect. See you in Berlin!
#ESMO2025#ESMO#MenariniStemline
@CAgovernor I get incessant fundraising text messages from your campaign. I have tried many times to report them as spam and unsubscribe. Please let me know how to be added to the do not contact list. Ty
Day 3 of #DAVABreast meeting in magical Kona. 🏝️ An honor to meet and learn from brilliant faculty, all committed to enhancing research and improving patient lives. Thank you @DAVAOnc for arranging such a valuable and engaging meeting of the minds! 🌸 @Dr_RShatsky@MSpencerSoCal